The objective of the current post hoc analysis was to evaluate the effect of specific biological and genetic markers on the antidepressant efficacy of adjunctive L-methylfolate @ mg versus placebo from a trial of inadequate responders to selective serotonin reuptake inhibitors ( SSRIs ) .